MTOR and angiosarcoma: In contrast to other sarcomas, angiosarcoma shows a very low level of alterations in the p53 and PIK3CA/AKT/mTOR pathways, and no PTEN alterations were identified in a series of primary and secondary angiosarcoma samples [14].